Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurrences on the basis of the topographic location, but its effectiveness in prognosis prediction has not been well investigated yet. Aims of this study are to analyze survival outcome of patients surgically treated for thymoma recurrence according to the ITMIG recurrence classification and to investigate possible alternatives. Methods: From January 1, 1990, to January 7, 2017, data on 135 surgically treated patients for thymoma recurrence from three high-volume centers were collected and retrospectively analyzed. Patients were classified according to the ITMIG classification as local, regional, and distant. The ITMIG classification and alternative...
OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value r...
ObjectivesThe treatment for recurrent thymoma remains a very controversial issue. This study aims to...
OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value r...
Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurren...
Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurren...
Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurren...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
AbstractObjective and methods: This study reports clinicopathologic features, treatment, and outcome...
OBJECTIVES: The treatment for recurrent thymoma remains a very controversial issue. This study aims ...
INTRODUCTION: Clinical outcomes and prognosis of recurrent thymoma are not well known because of its...
Introduction:Clinical outcomes and prognosis of recurrent thymoma are not well known because of its ...
OBJECTIVES: The treatment for recurrent thymoma remains a very controversial issue. This study aims ...
OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value r...
ObjectivesThe treatment for recurrent thymoma remains a very controversial issue. This study aims to...
OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value r...
Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurren...
Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurren...
Introduction: The International Thymic Malignancy Interest Group (ITMIG) classifies thymoma recurren...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
Objectives: Thymomas are rare neoplasms with a low recurrence rate, which are preferably surgically ...
AbstractObjective and methods: This study reports clinicopathologic features, treatment, and outcome...
OBJECTIVES: The treatment for recurrent thymoma remains a very controversial issue. This study aims ...
INTRODUCTION: Clinical outcomes and prognosis of recurrent thymoma are not well known because of its...
Introduction:Clinical outcomes and prognosis of recurrent thymoma are not well known because of its ...
OBJECTIVES: The treatment for recurrent thymoma remains a very controversial issue. This study aims ...
OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value r...
ObjectivesThe treatment for recurrent thymoma remains a very controversial issue. This study aims to...
OBJECTIVES: The World Health Organization (WHO) thymoma histological classification clinical value r...